Comparative efficacy of combined antihistamine and montelukast therapy in adult patients with atopic dermatitis
CONCLUSIONS: Comparison of data presenting the therapy outcomes in two groups showed that administration of the combined therapy was significantly more effective compared to the antihistamine monotherapy. The results revealed considerable efficacy of the combined therapy reinforced by the use of cysteinyl leukotriene receptor antagonist, montelukast.PMID:38533375 | PMC:PMC10962370 | DOI:10.5114/ada.2023.135759 (Source: Advances in Dermatology and Allergology)
Source: Advances in Dermatology and Allergology - March 27, 2024 Category: Dermatology Authors: Kristina R Jamalyan Helen G Azaryan Source Type: research
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
Br J Dermatol. 2024 Mar 27:ljae133. doi: 10.1093/bjd/ljae133. Online ahead of print.ABSTRACTThis retrospective study, using UK Clinical Practice Research Datalink and Hospital Episode Statistics databases, analysed 17,239 incident patients with vitiligo. Mean incidence of vitiligo was 0.16 (2010-2021) per 1000 person-years (range: 0.10 [2010-COVID] to 0.19 [2013/2018]); prevalence increased from 0.21% (2010) to 0.38% (2021). The most common comorbidities recorded after vitiligo diagnosis were diabetes (19.4%), eczema (8.9%), thyroid disease (7.5%), and rheumatoid arthritis (6.9%). Mental health diagnoses recorded at any ti...
Source: The British Journal of Dermatology - March 27, 2024 Category: Dermatology Authors: Viktoria Eleftheriadou Carine Delattre Shala Chetty-Mhlanga Christopher Lee Laura Girardat-Rotar Iftekhar Khan Amit Mathew Andrew R Thompson Source Type: research
Comparative efficacy of combined antihistamine and montelukast therapy in adult patients with atopic dermatitis
CONCLUSIONS: Comparison of data presenting the therapy outcomes in two groups showed that administration of the combined therapy was significantly more effective compared to the antihistamine monotherapy. The results revealed considerable efficacy of the combined therapy reinforced by the use of cysteinyl leukotriene receptor antagonist, montelukast.PMID:38533375 | PMC:PMC10962370 | DOI:10.5114/ada.2023.135759 (Source: Advances in Dermatology and Allergology)
Source: Advances in Dermatology and Allergology - March 27, 2024 Category: Dermatology Authors: Kristina R Jamalyan Helen G Azaryan Source Type: research
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
Br J Dermatol. 2024 Mar 27:ljae133. doi: 10.1093/bjd/ljae133. Online ahead of print.ABSTRACTThis retrospective study, using UK Clinical Practice Research Datalink and Hospital Episode Statistics databases, analysed 17,239 incident patients with vitiligo. Mean incidence of vitiligo was 0.16 (2010-2021) per 1000 person-years (range: 0.10 [2010-COVID] to 0.19 [2013/2018]); prevalence increased from 0.21% (2010) to 0.38% (2021). The most common comorbidities recorded after vitiligo diagnosis were diabetes (19.4%), eczema (8.9%), thyroid disease (7.5%), and rheumatoid arthritis (6.9%). Mental health diagnoses recorded at any ti...
Source: The British Journal of Dermatology - March 27, 2024 Category: Dermatology Authors: Viktoria Eleftheriadou Carine Delattre Shala Chetty-Mhlanga Christopher Lee Laura Girardat-Rotar Iftekhar Khan Amit Mathew Andrew R Thompson Source Type: research
Comparative efficacy of combined antihistamine and montelukast therapy in adult patients with atopic dermatitis
CONCLUSIONS: Comparison of data presenting the therapy outcomes in two groups showed that administration of the combined therapy was significantly more effective compared to the antihistamine monotherapy. The results revealed considerable efficacy of the combined therapy reinforced by the use of cysteinyl leukotriene receptor antagonist, montelukast.PMID:38533375 | PMC:PMC10962370 | DOI:10.5114/ada.2023.135759 (Source: Advances in Dermatology and Allergology)
Source: Advances in Dermatology and Allergology - March 27, 2024 Category: Dermatology Authors: Kristina R Jamalyan Helen G Azaryan Source Type: research
